Japan to approve Pfizer COVID-19 vaccine for 12- to 15-year-olds

A Japanese health ministry panel approved on Friday expanding the use of the U.S. pharmaceutical maker Pfizer Inc.'s COVID-19 vaccine for people aged 12 to 15 in addition to those 16 or older.The ministry is expected to decide at a meeting Monday to provide the vaccine free for those aged between 12 and 15.The panel also gave the green light to extending the vaccine's maximum storage period at temperatures between 2 and 8 C to one month from five days. For longer-term storage, the Pfizer vaccine needs to be kept at a temperature of around minus 75 C.Pfizer has been working with the Pharmace…READ FULL ARTICLE